Key Details
Price
$1.03Annual Revenue
$11.03 MAnnual EPS
-$0.62Annual ROE
-42.51%Beta
0.84Events Calendar
Next earnings date:
Mar 21, 2025Recent quarterly earnings:
Nov 12, 2024Recent annual earnings:
Mar 21, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
Hyperfine, Inc. (NASDAQ:HYPR ) Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ET Company Participants Marissa Bych - Gilmartin Group Maria Sainz - President and CEO Brett Hale - Chief Administrative Officer and CFO Conference Call Participants Yuan Zhi - B. Riley Operator Good afternoon.
Hyperfine, Inc. (HYPR) came out with a quarterly loss of $0.14 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.15 per share a year ago.
Hyperfine announces a publication on using the Swoop system for patients on ECMO support. The study showed the safety of using an ultra-low-field portable brain MRI on patients undergoing ECMO.
Compared to conventional MRI, which takes an average of 27.7 hours, the Swoop system of HYPR operates with a median time-to-scan of 2.5 hours.
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced a collaboration with the Medical University of South Carolina to assess the brains of astronauts before and after embarking on the Polaris Dawn mission. Researchers will utilize the Swoop® Portable MR Imaging® system at a SpaceX facility in.
Hyperfine, Inc. (NASDAQ:HYPR ) Q2 2024 Earnings Call August 8, 2024 4:30 PM ET Company Participants Marissa Bych - Investor Relations Maria Sainz - President and Chief Executive Officer Brett Hale - Chief Administrative Officer and Chief Financial Officer Conference Call Participants Yuan Zhi - B. Riley Operator Good afternoon, and welcome to Hyperfine's Second Quarter 2024 Earnings Conference Call.
Hyperfine, Inc. (HYPR) came out with a quarterly loss of $0.14 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.15 per share a year ago.
Hyperfine (HYPR) announces the receipt of FDA clearance for its ninth-generation AI-powered Swoop system software.
Hyperfine (HYPR) announces that it has signed agreements with experienced and accomplished distributors in Germany, Austria, Switzerland, and key Nordic markets for its Swoop, a portable MRI system.
Hyperfine, Inc. (NASDAQ: HYPR) will be holding its Q1 2024 Earnings Conference Call on May 13, 2024 at 4:30 PM ET. The call will be led by Marissa Bych from Gilmartin Group, Investor Relations, Maria Sainz, President and CEO, and Brett Hale, CAO and CFO. Xuyang Li from Jefferies will also be present. Good afternoon, and thank you for joining the Hyperfine's Q1 2024 Earnings Conference Call. All participants are currently in listen-only mode.
FAQ
- What is the primary business of Hyperfine?
- What is the ticker symbol for Hyperfine?
- Does Hyperfine pay dividends?
- What sector is Hyperfine in?
- What industry is Hyperfine in?
- What country is Hyperfine based in?
- When did Hyperfine go public?
- Is Hyperfine in the S&P 500?
- Is Hyperfine in the NASDAQ 100?
- Is Hyperfine in the Dow Jones?
- When was Hyperfine's last earnings report?
- When does Hyperfine report earnings?
- Should I buy Hyperfine stock now?